The SNS Insider report estimates the Circulating Tumor Cells Market size at USD 11.35 billion in 2023, with a projected CAGR of 13.8% to reach USD 36.33 billion by 2032.
The rise in cancer diagnosis and treatment drives the growth of the circulating tumor cells market. Another major driver is the minimally invasive nature of CTC analysis. The traditional biopsies, are complex and sometimes risky, CTC testing provide a simpler and more patient friendly approach. This is due to rise in global cancer cases. For instance, Pan American Health Organization reported nearly 20 million new diagnoses in 2023.
Early detection and accurate diagnosis is important for effective cancer management, and CTC technology provide solution. The CTC is important in diagnosing breast cancer, the most prevalent cancer in the American women. The increasing cancer burden also increased investment in research and development (R&D) for novel treatment options. CTCs can be used to select suitable patients for clinical trials and monitor their response for innovative therapies. This benefits patients with the access to cutting-edge care. The ability of the CTCs for treatment is another factor driving the growth of the market. By studying the genetic makeup of CTCs, doctors are able to develop targeted treatment plans specific to each patient’s different cancer profile. This personalized approach is important for improving treatment outcomes and patient survival rates.
The increase in the adoption of biomarker tests, which used CTCs, allows minimally invasive screening of tumors before the complex surgical procedures like radiotherapy, chemotherapy, or surgical removal. The increasing importance of the non-invasive procedures due to their lower risk and faster recovery times has impact on the Circulating Tumor Cells Market. Circulating Tumor Cells Market growth is driven by its ability to provide minimally invasive, early detection of cancer, treatment selection, and the personalized treatment plans.
Get Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3952
KEY MARKET SEGMENTATION
By Technology
- CTC Detection & Enrichment Methods
- Immunocapture (Label-based)
- Positive Selection
- Negative Selection
- Size-based Separation (Label-free)
- Membrane-based
- Microfluidic-based
- Density-based Separation (Label-free)
- Combined Methods (Label-free)
- Immunocapture (Label-based)
- CTC Direct Detection Methods
- SERS
- Microscopy
- Others
- CTC Analysis
By Product
- Kits & Reagents
- Blood Collection Tubes
- Devices or Systems
By Specimen
- Blood
- Bone Marrow
- Other Body Fluids
By Application
- Clinical/Liquid Biopsy
- Risk Assessment
- Screening and Monitoring
- Research
- Cancer Stem Cell & Tumorogenesis Research
- Drug/Therapy Development
Segment Analysis
By Technology, CTC Detection & Enrichment Methods dominated the segment of Circulating Tumor Cells Market with more than 65.4% of market share in 2023, due to various techniques are available for enriching circulating tumor cells detection.
By Application, Research dominated the segment of Circulating Tumor Cells Market with high market share in 2023, due to the important role CTCs play in understanding cancer metastasis, and the spread of cancer cells to other organs.
By Product, Kits & Reagents dominated the segment of Circulating Tumor Cells Market with high market share in 2023, due to the high level of customer interest in the product or service, leading to frequent repurchases.
Recent Developments
August 2023, Cell Microsystems acquired Fluxion Biosciences and increase its expertise in measuring electrical currents in cell membranes.
June 2023, Bio-Techne announced the acquisition of LunaPhore. This aims to create a comprehensive workflow for researchers studying tissues, streamlining the research process and potentially leading to new discoveries.
May 2023, Menarini Silicon Biosystems partnered with Alivio Health to offer Alivio’s clients access to CELLSEARCH liquid biopsy tests.
March 2023, Miltenyi Biotec acquired Lino Biotech AG, for access to their innovative biosensor technology.
Key Players
- QIAGEN
- Bio-Techne Corporation
- Thermo Fisher Scientific Inc.
- Precision for Medicine
- AVIVA Biosciences
- BIOCEPT Inc.
- Fluxion Biosciences Inc.
- Greiner Bio One International GmbH
- Ikonisys Inc.
- Miltenyi Biotec
- Menarini Silicon Biosystems
- LineaRx Inc. (Vitatex Inc.)
- STEMCELL Technologies
Regional Analysis
The North America led the Circulating Tumor Cells Market with more than 35.7% of market share in 2023. Due to the presence of leading companies like Aviva Biosciences, Apocell, Inc., and Advanced Cell Diagnostics. These players take strategic initiatives to enhance their market hold, and continuously innovating and refining CTC technologies. The increase in the incidence of cancer in North America increases the demand for advanced diagnostics like CTC. The increase in the regulatory approvals for CTC technologies and high investments in research and development further rises the market growth in this region.
The Asia Pacific region is the fastest growing region for the Circulating Tumor Cells Market increase in the diagnostic capabilities for cancer patients in many Asia Pacific countries. CTC technology provide a different opportunity to address this need and improve overall cancer care in the region. The increase in the public awareness about the early cancer detection and risk assessment is rapidly increase in this region. CTC testing provide early intervention and improved patient compliance.
Key Takeaways
- The report clarifies that a key driver for CTC adoption is its minimally invasive nature compared to traditional biopsies. This patient-friendly approach is particularly valuable given the increasing global cancer burden.
- The report emphasizes the importance of early detection and accurate diagnosis for effective cancer management.
- This allows for minimally invasive tumor screening before complex surgical procedures, catering to the growing demand for non-invasive approaches that offer faster recovery times.
- The report identifies North America as the current leader due to the presence of leading companies and high cancer incidence.
Make Enquiry About Circulating Tumor Cells Market Report: https://www.snsinsider.com/enquiry/3952
Table of Content
Chapter 1 Introduction
Chapter 2 Research Methodology
Chapter 3 Circulating Tumor Cells Market Dynamics
Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)
Chapter 5 Value Chain Analysis
Chapter 6 Porter’s 5 forces model
Chapter 7 PEST Analysis
Chapter 8 Circulating Tumor Cells Market Segmentation, By Technology
Chapter 9 Circulating Tumor Cells Market Segmentation, By Product
Chapter 10 Circulating Tumor Cells Market Segmentation, By Specimen
Chapter 11 Circulating Tumor Cells Market Segmentation, By Application
Chapter 12 Circulating Tumor Cells Market – Regional Analysis
Chapter 13 Company profile
Chapter 14 Competitive Landscape
Chapter 15 Use Case and Best Practices
Chapter 16 Conclusion
Access This Full Report with Charts And Graphs @ https://www.snsinsider.com/reports/circulating-tumor-cells-market-3952
Other Related Report
Blood Transfusion Diagnostics Market
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
info@snsinsider.com,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com/
